Skip to main content
Figure 3 | Pediatric Rheumatology

Figure 3

From: A comparative proteomic study of sera in paediatric systemic lupus erythematosus patients and in healthy controls using MALDI-TOF-TOF and LC MS–A pilot study

Figure 3

A Enlarged areas of the control and patient gels showing a comparison of the expressions of spot A10 Apolipoprotein A1 (down regulated in disease as indicated by black arrow) in these gels. On the left is a control gel and on the right is a patient gel. B Enlarged areas of the control and patient gels showing a comparison of the expressions of spot A21 Transthyretin Variant del 122 was over expressed in disease gel (indicated by black arrow) in these gels. On the left is a control gel and on the right is a patient gel.

Back to article page

Pediatric Rheumatology

ISSN: 1546-0096